Stock data

漢達 (6620)

漢達 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$70.41M, down 20.1% from a year earlier. EPS over the last four quarters totals NT$3.08.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 漢達 in Insightr